Intratumoral bacteria linked to myeloid inflammation and progression in kidney cancer (TRACERx Renal)

Study · UroToday · 2026-10-28. Number 5 in the UrologyWatch Top 5 for October 29, 2026.

A TRACERx Renal study reports that bacteria detected inside kidney tumors are associated with myeloid inflammation and disease progression.

Why it matters: Raises the question of a tumor microbiome role in RCC biology, though causality and clinical implications remain unclear.

Limitation: Associative findings from a correlative study; causal role of bacteria in progression not established.

Source: UroToday · PubMed 42914984 · DOI 10.1016/j.medj.2026.101335

The full October 29, 2026 edition · Today's urology news